Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125483831 | 12548383 | 1 | I | 2015 | 20160105 | 20160712 | 20160712 | EXP | BR-PFIZER INC-2016004745 | PFIZER | 67.00 | YR | F | Y | 80.00000 | KG | 20160712 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125483831 | 12548383 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP IN EACH EYE, 1X/DAY | U | L31214 | 20597 | 2 | GTT | EYE DROPS, SOLUTION | QD | ||||
| 125483831 | 12548383 | 2 | SS | XALATAN | LATANOPROST | 1 | UNK | U | L23965 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 125483831 | 12548383 | 3 | SS | XALATAN | LATANOPROST | 1 | UNK | U | AO8013 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 125483831 | 12548383 | 4 | SS | XALATAN | LATANOPROST | 1 | UNK | U | AO7466 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 125483831 | 12548383 | 5 | C | LIMBITROL /00033501/ | 2 | 2 TABLETS, DAILY | 0 | 2 | DF | TABLET | |||||||||
| 125483831 | 12548383 | 6 | C | METHOTREXATE. | METHOTREXATE | 1 | 4 TABLETS, WEEKLY | 0 | 4 | DF | TABLET | /wk | |||||||
| 125483831 | 12548383 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | TABLET | |||||||||||
| 125483831 | 12548383 | 8 | C | PACO | ACETAMINOPHENCODEINE PHOSPHATE | 1 | UNK, 3X/DAY | 0 | TID | ||||||||||
| 125483831 | 12548383 | 9 | C | LEXOTAN | BROMAZEPAM | 1 | UNK | 0 | |||||||||||
| 125483831 | 12548383 | 10 | C | REFRESH OPTIVE ADVANCED /07868701/ | 2 | UNK | 0 | ||||||||||||
| 125483831 | 12548383 | 11 | C | DORFLEX | CAFFEINEDIPYRONEORPHENADRINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125483831 | 12548383 | 1 | Glaucoma |
| 125483831 | 12548383 | 2 | Intraocular pressure test |
| 125483831 | 12548383 | 5 | Nervous system disorder |
| 125483831 | 12548383 | 6 | Polymyositis |
| 125483831 | 12548383 | 7 | Immunosuppressant drug therapy |
| 125483831 | 12548383 | 8 | Pain |
| 125483831 | 12548383 | 10 | Eye lubrication therapy |
| 125483831 | 12548383 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125483831 | 12548383 | OT |
| 125483831 | 12548383 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125483831 | 12548383 | Condition aggravated | |
| 125483831 | 12548383 | Dizziness | |
| 125483831 | 12548383 | Drug dose omission | |
| 125483831 | 12548383 | Dysstasia | |
| 125483831 | 12548383 | Eye pain | |
| 125483831 | 12548383 | Eyelid pain | |
| 125483831 | 12548383 | Fatigue | |
| 125483831 | 12548383 | Gait disturbance | |
| 125483831 | 12548383 | Incorrect dose administered | |
| 125483831 | 12548383 | Insomnia | |
| 125483831 | 12548383 | Intervertebral disc protrusion | |
| 125483831 | 12548383 | Intraocular pressure increased | |
| 125483831 | 12548383 | Pneumonia | |
| 125483831 | 12548383 | Stress | |
| 125483831 | 12548383 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125483831 | 12548383 | 5 | 1996 | 0 | ||
| 125483831 | 12548383 | 6 | 2006 | 0 | ||
| 125483831 | 12548383 | 8 | 1996 | 0 | ||
| 125483831 | 12548383 | 10 | 2015 | 0 |